High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$892K
$892,732
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
Other
|
2026-03-30 | $78,150 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 Sell
|
2026-03-30 | $23,714 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Dandekar Atul
• Officer • CSBO
10b5-1 SellΔOwn -37.3%
2026-03-30
$196,305
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 SellΔOwn -37.3%
|
2026-03-30 | $196,305 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Dandekar Atul
• Officer • CSBO
10b5-1 SellΔOwn -20.8%
2026-02-27
$168,756
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 SellΔOwn -20.8%
|
2026-02-27 | $168,756 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
Other
|
2026-02-27 | $78,150 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Dandekar Atul
• Officer • CSBO
10b5-1 SellΔOwn -26.4%
2026-02-27
$171,967
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 SellΔOwn -26.4%
|
2026-02-27 | $171,967 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 Sell
|
2026-01-29 | $51,821 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Dandekar Atul
• Officer • CSBO
10b5-1 SellΔOwn -21.1%
2026-01-29
$126,022
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 SellΔOwn -21.1%
|
2026-01-29 | $126,022 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Dandekar Atul
• Officer • CSBO
10b5-1 SellΔOwn -20.8%
2026-01-29
$154,147
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
10b5-1 SellΔOwn -20.8%
|
2026-01-29 | $154,147 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • CSBO
Other
|
2026-01-29 | $78,150 | M | Form 4 |